Literature DB >> 19527320

Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study.

Lorenzo Fácila1, Vicente Bertomeu, Vicente Bertomeu-González, Pedro Morillas, Pilar Mazón, Jose R González-Juanatey.   

Abstract

The association between renal dysfunction and cardiovascular risk in patients with hypertension and left ventricular hypertrophy (LVH) has not been specifically studied. The aim of this study was to analyze the association between renal function and the presence of cardiovascular disease in this group of patients. Hypertensive patients with electrocardiographic criteria for LVH were recruited in cardiology outpatient clinics from April 2003 until November 2004. Epidemiologic variables were determined, together with an estimation of the glomerular filtration rate by means of the Modification of Diet in Renal Disease (MDRD) and Crockoft-Gault equations. The population was classified according to the kidney disease stages of the National Kidney Foundation. A total of 3962 patients were included in the study, 47.6% of which were female, with a mean age of 67.2 years. The prevalence of established cardiovascular disease was higher in patients with a depressed glomerular filtration rate (68.3% vs 54.9%; P<.001). After adjusting for age, sex, body mass index, diabetes, smoking habits, and systolic and diastolic blood pressures, the stage of renal function was an independent predictor of the presence of cardiovascular disease (odds ratio, 1.5 [confidence interval, 1.19-2.02]; 2.1 [1.55-2.89]; and 2.6 [1.52-4.42], respectively, for stages 2, 3, 4-5, compared with stage 1). In hypertensive patients with electrocardiographic criteria for LVH, the determination of the glomerular filtration rate by the MDRD or Crockoft equations is easy and identifies a progressive and independent increase in cardiovascular risk.

Entities:  

Mesh:

Year:  2009        PMID: 19527320      PMCID: PMC8673365          DOI: 10.1111/j.1751-7176.2009.00122.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure.

Authors:  Vicente Bertomeu-Gonzalez; Julio Núñez; Eduardo Núñez; Lorenzo Fácila; Juan Sanchis; Vicent Bodí; Mauricio Pellicer; María J Bosch; Angel Martínez; Francisco J Chorro; Angel Llàcer
Journal:  Int J Cardiol       Date:  2005-11-10       Impact factor: 4.164

2.  Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study.

Authors:  Luis M Ruilope; Antonio Salvetti; Kenneth Jamerson; Lennart Hansson; Ingrid Warnold; Hans Wedel; Alberto Zanchetti
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

3.  [Renal function and cardiovascular risk in patients with essential hypertension. The "FRESHA" study].

Authors:  P Herrero; R Marín; F Fernández Vega; M Gorostidi; A Riesgo; J Vázquez; B Díez Ojeda
Journal:  Nefrologia       Date:  2006       Impact factor: 2.033

4.  High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension.

Authors:  G Schillaci; G Reboldi; P Verdecchia
Journal:  Arch Intern Med       Date:  2001-03-26

5.  Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?

Authors:  Lorenzo Fácila; Julio E Nuñez; Vicente Bertomeu G; Juan Sanchis; Vicent Bodi; Fco J Chorro; Angel Llacer; Fco J Chorro
Journal:  Int J Cardiol       Date:  2005-04-20       Impact factor: 4.164

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.

Authors:  Josep Redón; Luis Cea-Calvo; José V Lozano; Cristina Fernández-Pérez; Jorge Navarro; Alvaro Bonet; Jorge González-Esteban
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

9.  Association between serum homocysteine and markers of impaired kidney function in adults in the United States.

Authors:  Mildred E Francis; Paul W Eggers; Thomas H Hostetter; Josephine P Briggs
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  2 in total

1.  The association between elevated cystatin C levels with myocardial infarction: a meta-analysis.

Authors:  Minghui Bi; Zhuo Huang; Peng Li; Cheng Cheng; Yuli Huang; Weibing Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Simultaneous cardiac and renal damage in a hypertensive population.

Authors:  Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-06       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.